![](/img/cover-not-exists.png)
Single‐Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial)
García‐Alfonso, Pilar, Benavides, Manuel, Falcó, Esther, Muñoz, Andrés, Gómez, Auxiliadora, Sastre, Javier, Rivera, Fernando, Montagut, Clara, Salgado, Mercedes, López‐Ladrón, Amelia, López, Rafael, RLanguage:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2018-0316
Date:
August, 2018
File:
PDF, 278 KB
english, 2018